glp-1 alcohol addiction GLP‐1 Receptor Agonists for Treating Use Disorder: A Critical Review - Woo - 2026 - Alcohol, Clinical and Experimental Research GLP-1 Anti-Obesity Rx and Alcohol

Key takeaways TRICARE typically covers Ozempic for Type 2 diabetesbut not for weight loss, which is an off-label use

Clinical studies have shown that GLP-1 medications can effectively promote weight loss in patients who do not have diabetes

[1] [2] It is administered as a once-daily subcutaneous injection and is intended for use alongside a reduced-calorie diet and increased physical activity

MaizteguiBBoggioVRomanCLFloresLEZottoHDRopoloAet al

Rapid weight loss may contribute to temporary musculoskeletal adjustment as body mechanics and postural alignment change

As research progresses and policies evolve, the future of GLP-1 therapies will depend on finding a balance between innovation, accessibility, and sustainability .